NovaForm Wound Matrix Distribution
Advanced wound care
CommercialActive
Key Facts
About NovaBone
NovaBone is an established, commercial-stage player in the osteobiologics market, with over 20 years of experience and millions of devices used clinically. The company's core technology is a family of bioactive synthetic bone grafts that actively participate in the healing process by releasing ions and modulating cellular activity. It serves both the orthopedic (e.g., spinal fusion, fracture repair) and dental (e.g., sinus lifts, periodontal defects) surgery markets through direct and partnership-driven distribution. NovaBone operates as a private company, leveraging a portfolio of clinically validated products and strategic partnerships to drive growth.
View full company profileTherapeutic Areas
Other Advanced wound care Drugs
| Drug | Company | Phase |
|---|---|---|
| Microcyn®/Oxum® (Rx) | Sonoma Pharmaceuticals | Commercial |
| Dermacyte Matrix | Merakris Therapeutics | Commercial |
| XLR8+ Multi-Level Intensity | Genadyne Biotechnologies | Commercial |
| Nexodyn® AOS | APR Applied Pharma Research | Marketed |
| Hydrofiber® EVOLUTION | ConvaTec | Commercial |